AzTrials
AzTrials

Airway ManagementNCT02897518

Videolaryngoscopes for Tracheal Intubation

A study testing Imago V-Balde and Glidescope in people with Airway Management, run by Federico II University at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary end point of this study is the feasibility of intubation. The secondary end-points are the success to intubate in the first attempt, the intubation time, the Cormack and Lehane score view, the comparison of the intubation difficulty scale (IDS) score and the need for maneuvers to aid the endotracheal… Read more about this study

Who is it for?
Ages 18 to 77 years
Conditions the study is for
Airway Management
What is being tested?
Imago V-Balde and Glidescope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteItaly
Study dates
Jan 2015to Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 77 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age>18 years
  • Mallampati class 3-4
  • inter-incisor distance < 30 mm
  • mental-thyroidal distance < 60 mm
  • large prominence of superior incisors above inferior incisors uncorrectable with jaw-thrust -reduced head and neck motility
  • reduced mental-jugular distance.

Who cannot join

  • < 1 criteria for predicted difficult airway
  • emergency surgery
  • age < 18 years
  • declined consent to participate

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • University of Naples Federico II department of Anesthesia and Critical Care

    Naples, Italy, 80100

Other trials in Italy

About this study

Official title: Comparison Between Imago V-Blade and Glidescope During Endotracheal Intubation: a Feasibility Study

The primary end point of this study is the feasibility of intubation. The secondary end-points are the success to intubate in the first attempt, the intubation time, the Cormack and Lehane score view, the comparison of the intubation difficulty scale (IDS) score and the need for maneuvers to aid the endotracheal intubation comparing Imago V-Blade ® and Glidescope®.

Patients admit to the operation rooms of University of Naples "Federico II" and requiring endotracheal intubation for general anesthesia will be consecutively screened for the presence of predicted difficult airway according Italian guideline. According to this guideline, the presence of one or more of the following parameters may be considered highly predictive of difficult intubation: Mallampati class 3-4, inter-incisor distance < 30 mm, mental-thyroidal distance < 60 mm, large prominence of superior incisors above inferior incisors uncorrectable with jaw-thrust, reduced head and neck motility, and reduced mental-jugular distance. Patients matching more then 1 of the previous criteria stated by Italian guideline will be included in this case controlled study. Patients 1) without criteria for predicted difficult airway; 2) those requiring emergency surgery; 3) aged < 18 years; or 4) declined consent to participate, will be excluded from this study.The primary end-point was the comparison of the intubation difficulty scale (IDS) score. The secondary end-points were the learning curve, the intubation time, the Cormack and Lehane score view, and the need for maneuvers to aid the endotracheal intubation comparing different videolaryngoscopes available in our department. Two anesthesiologists with 10 years of experience in conventional endotracheal intubation and trained for video assisted intubation will perform the maneuvers.

Being tested
Imago V-Balde, Glidescope
Keywords
Videolaryngoscopes, Intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Imago V-BaldeDevice

    the endotracheal intubation will be performed with videolaryngoscopes (imago V-Blade) according to the user manual

  • GlidescopeDevice

    the endotracheal intubation will be performed with videolaryngoscopes (Glidescope) according to the user manual

Study groups in NCT02897518
Study groupRoleWhat they receive
endotracheal intubation with Imago V-bladeExperimentalPatients in this arm will receive endotracheal intubation with the Imago V-Blade videolaryngoscopes.
Receives: Device: Imago V-Balde
endotracheal intubation with GlidescopeActive comparatorPatients in this arm will receive endotracheal intubation with the glidescope videolaryngoscopes.
Receives: Device: Glidescope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. feasibility of endotracheal intubation

    Measured: within 60 seconds

Secondary outcomes (5)
  1. Success rate of endotracheal intubation using Imago V-Blade compared with Glidescope

    Time to reach a successful endotracheal intubation from the beginning of indirect laryngoscopy to the confirmation of the intubation with the evaluation of the end-tidal carbon dioxide

    Measured: wthin 120 seconds

  2. Intubation time

    time to reach endotracheal intubation from the beginning of indirect laryngoscopy to the confirmation of the intubation with the evaluation of the end-tidal carbon dioxide

    Measured: wthin 120 seconds

  3. Cormack and Lehane score view

    Measured: During endotracheal intubation

  4. use of adjunctive maneuvers to aid the endotracheal intubation

    the investigators evaluated the necessary maneuvers to aid a successful endotracheal intubation as number of Readjusting patient's head, number of external laryngeal pressure, number of advancement or withdrawal the blade and number of increased lifting force

    Measured: During endotracheal intubation

  5. Intubation difficulty scale score

    Time to pass the vocal cord during the successful endotracheal intubation measured from the beginning of indirect laryngoscopy to the confirmation of the intubation with the evaluation of the end-tidal carbon dioxide

    Measured: within 60 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2016 (estimated)
  2. Study startJan 2015
  3. Primary completionJan 2016
  4. Study completionJan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02897518
Sponsor's protocol ID
Airway1
Status last verified
Jan 2017
First submitted
25 Aug 2016
Last updated
5 Jan 2017
Results posted
No
Data monitoring committee
No

Publications

  • Vargas M, Pastore A, Aloj F, Laffey JG, Servillo G. A comparison of videolaryngoscopes for tracheal intubation in predicted difficult airway: a feasibility study. BMC Anesthesiol. 2017 Feb 20;17(1):25. doi: 10.1186/s12871-017-0318-2.

    PubMed 28219331

Questions about this trial

What is this clinical trial studying?

A study testing Imago V-Balde and Glidescope in people with Airway Management, run by Federico II University at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

feasibility of endotracheal intubation (time frame: within 60 seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02897518, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in